Treatment interruption and discontinuation of hormonal therapy in hormone receptor-positive breast c...
Treatment interruption and discontinuation of hormonal therapy in hormone receptor-positive breast cancer patients
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Purpose
To investigate predictors of treatment interruption and early discontinuation of adjuvant hormonal therapy (HT) in a retrospective cohort of women with newly diagnosed hormone receptor-positive (HR +) breast cancer.
Methods
Eligible cases were identified from a single institutional tumor registry from 2009 to 2015. Patients were fo...
Alternative Titles
Full title
Treatment interruption and discontinuation of hormonal therapy in hormone receptor-positive breast cancer patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11372730
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11372730
Other Identifiers
ISSN
0167-6806,1573-7217
E-ISSN
1573-7217
DOI
10.1007/s10549-020-05892-z
